AC-101

DRUG2 trials

Sponsors

Accro Bioscience (Suzhou) Limited

Conditions

Ulcerative ColitisUlcerative Colitis (UC)

Phase 1

A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis

RecruitingNCT07083193

Accro Bioscience (Suzhou) LimitedUlcerative Colitis

Start: 2025-01-20End: 2027-04-30Target: 24Updated: 2025-07-24

Phase 2

A Study of AC-101 Tablets in Patients With Ulcerative Colitis

Not yet recruitingNCT07755241

Accro Bioscience (Suzhou) LimitedUlcerative Colitis (UC)

Start: 2026-08-28End: 2028-02-28Target: 153Updated: 2026-08-17